Now showing items 1-5 of 5
Adherence to anti-retroviral therapy in the federal capital territory, Abuja, Nigeria
Background Nigeria accounted for 2.95 million of the 22 million people globally living with HIV in 2008. In 2010, the HIV prevalence increased to 3.1 million, with 1.5 million people requiring anti-retroviral treatment ...
Adherence to highly active antiretroviral therapy among patients in the Keetmanshoop antiretroviral therapy programme, Namibia
The government of Namibia established a comprehensive HIV/AIDS treatment and care programme in 2002. This programme provides anti-retroviral treatment to all eligible HIV patients in the public health sector. The antiretroviral ...
Factors associated with poor adherence amongst patients receiving antiretroviral therapy at the intermediate hospital Oshakati in Namibia
(University of the Western Cape, 2011)
Namibia is severely affected by the HIV/AIDS epidemic, with an estimated HIV prevalence of 17.8%. A comprehensive, public HIV/AIDS treatment and care programme was established in 2003 by the government of Namibia in ...
Adherence, retention in care and treatment outcomes of adolescents on antiretroviral therapy in the Western Cape Metropole in South Africa
(University of the Western Cape, 2017)
Approximately 6% of all people living with HIV in 2016 are adolescents aged 10-19 years. It is reported globally that adolescents on antiretroviral therapy (ART) are at increased risk for poor retention in care, adherence ...
Exploration of adherence to treatment challenges experienced by HIV positive adolescents in Insiza District, Zimbabwe
(University of the Western Cape, 2019)
Zimbabwe has a high burden of HIV with a prevalence of 13.8% among the 15 to 49-year old population in 2016. As at 2017, the national antiretroviral treatment (ART) programme initiated over 1.1 million people living with ...